Company Overview
ICICI Bank Limited, together with its subsidiaries, engages in the provision of various banking and financial services to corporate and retail customers in India and internationally. The company operates through Retail Banking, Wholesale Banking, Treasury, Other Banking, Life Insurance, General Insurance, and Others segments. The company offers asset management, securities brokerage, private equity, foreign exchange, agricultural and rural banking, equities underwriting, depositary share accounts, consumer durable goods financing, corporate salary and current account, savings and sovereign gold bonds, insurance policies, public offerings, investment, credit and protection, retail inward remittances, certificates of deposits, and payment and transaction banking products and services. It is also involved in the fee and commission-based activities; distribution of financial products; venture capital and real estate fund management business; treasury and rural banking operations; financial solutions; working capital financing; I-Process services, mutual funds, investment banking, and pension funds; and advisory activities. In addition, the company provides savings, salary, capital gains scheme, Hindu undivided family savings, real estate regulatory authority, government e-marketplace, current, trade, escrow, and foreign currency accounts. Further, it offers personal, home, car, education, gold, automobile, and commercial business loans, as well as loans against time deposits, securities, and property; and working capital loans, as well as credit, debit, prepaid, travel, forex, commercial, and corporate cards. Additionally, the company provides fixed income products; investment products; payments; general, accident, life, health, vehicle, and travel insurance products; cash management and merchant services; capital market and securities market services; and forex, derivatives, bullion, and bonds. The company was founded in 1955 and is headquartered in Mumbai, India.
Why Investors Should Care
Generates a return on equity of 16.1%, reflecting efficient use of shareholder capital.
Net profit has compounded at 16.8% per year over the last five years.
Revenue has grown at a 18.1% CAGR over the past five years.
Maintains a net profit margin of 27.5%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Mar 2026 Revenue of $2.23T (+9.1% YoY); net profit $542.08B.
- Trailing 12 Months Year-on-year growth — revenue +11.4%, earnings +13.8%.
- 5-Year Trend Long-term compounding — revenue CAGR 18.1%, profit CAGR 16.8%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 18.11% |
| 1 Year: | 11.40% |
Compounded Profit Growth
| 5 Years: | 16.78% |
| 1 Year: | 13.80% |
Stock Price Performance
| 1 Year: | -8.83% |
| 6 Months: | +6.27% |
| 3 Months: | +15.86% |
| 1 Month: | -2.28% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMAAbove
- RSI (14)45.44 · Neutral
P/E of 18.34 is above the sector median of 12.89 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 27.5%.
- Compounding revenue at 18.1% over 5 years.
- Profit CAGR of 16.8% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Financial Services).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | IBN ICICI Bank Limited FINANCIAL | 29.53 | 18.34 | $105.98B | 0.89% | - | 16.07% | 18.11% | 16.78% |
| 2 | JPM JPMorgan Chase & Co. SPXR3KFINANCIAL | 353.51 | 15.15 | $939.70B | 1.72% | - | 17.79% | 12.50% | 14.83% |
| 3 | BRK-B Berkshire Hathaway Inc. SPXFINANCIAL | 505.83 | 12.72 | $712.23B | 0.00% | - | 12.12% | 4.18% | 9.44% |
| 4 | V Visa Inc. SPXR3KFINANCIAL | 368.64 | 31.35 | $628.20B | 0.72% | 37.15% | 61.19% | 14.33% | 13.04% |
| 5 | MA Mastercard Incorporated SPXR3KFINANCIAL | 570.89 | 31.44 | $496.37B | 0.62% | 60.19% | - | 12.29% | 19.21% |
| 6 | BAC Bank of America Corporation SPXR3KFINANCIAL | 62.39 | 14.41 | $436.28B | 2.04% | - | 11.20% | 3.14% | 4.27% |
| 7 | BRK-A Berkshire Hathaway Inc. FINANCIAL | 757,791.00 | 12.71 | $370.14B | 0.00% | - | 12.12% | 7.60% | 10.02% |
| 8 | HSBC HSBC Holdings plc FINANCIAL | 106.26 | 15.18 | $363.70B | 3.65% | - | 13.10% | 9.75% | 12.72% |
| 9 | MS Morgan Stanley SPXR3KFINANCIAL | 216.24 | 17.48 | $339.62B | 2.26% | - | 17.97% | 3.76% | 9.66% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 356.14B | 346.05B | 352.93B | 357.42B | 383.66B |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - |
| Operating Income | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - |
| Interest Expense | - | 230.90B | 220.17B | 218.74B | 220.47B | 230.64B |
| Pretax Income | - | 195.57B | 191.26B | 178.24B | 208.13B | 213.74B |
| Tax Provision | - | 51.01B | 48.08B | 43.43B | 51.32B | 50.97B |
| Net Income | - | 135.58B | 133.57B | 125.38B | 147.55B | 154.40B |
| Diluted EPS | - | 37.42 | 36.84 | 34.58 | 40.72 | 42.58 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 1.36T | 1.61T | 2.05T | 2.23T |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - |
| Operating Income | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| Interest Expense | - | 505.43B | 741.08B | 890.28B | 890.29B |
| Pretax Income | - | 354.61B | 615.08B | 730.04B | 773.20B |
| Tax Provision | - | 117.93B | 154.28B | 184.35B | 193.84B |
| Net Income | - | 340.37B | 442.56B | 510.29B | 542.08B |
| Diluted EPS | - | 95.68 | 123.92 | 142.28 | 149.54 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Total Assets | 19.58T | 23.64T | 26.42T | 29.14T |
| Current Assets | - | - | - | - |
| Cash & Equivalents | 1.64T | 1.90T | 2.38T | 2.90T |
| Inventory | - | - | - | - |
| Receivables | 151.10B | 208.55B | 238.38B | 236.60B |
| Total Liabilities | 17.37T | 20.94T | 23.13T | 25.35T |
| Current Liabilities | - | - | - | - |
| Long Term Debt | 1.74T | 1.84T | 1.81T | 1.83T |
| Total Debt | 1.84T | 2.01T | 2.04T | 2.08T |
| Total Equity | 2.14T | 2.56T | 3.14T | 3.63T |
| Shares Outstanding | 6.98B | 7.02B | 7.12B | 7.16B |
Cash Flows (Annual)
Figures in USD.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -37.71B | 1.57T | 1.23T | 673.25B |
| Investing Cash Flow | - | -680.05B | -1.46T | -772.88B | -130.14B |
| Financing Cash Flow | - | 247.91B | 137.65B | 55.89B | -46.61B |
| Capital Expenditure | - | -24.68B | -36.79B | -47.70B | -37.30B |
| Free Cash Flow | - | -62.39B | 1.54T | 1.18T | 635.95B |
| Net Change in Cash | - | -469.86B | 251.18B | 511.06B | 496.51B |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | 25.1% | 27.5% | 24.9% | 24.3% |
| ROE % | - | 15.9% | 17.3% | 16.3% | 14.9% |
| ROCE % | - | - | - | - | - |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Morgan Stanley | 1.52% | 54.40M | $1.53B |
| 2 | WCM Investment Management, LLC | 1.44% | 51.51M | $1.45B |
| 3 | GQG Partners LLC | 0.86% | 30.90M | $869.79M |
| 4 | Temasek Holdings (Private) Ltd | 0.81% | 29.20M | $821.86M |
| 5 | Invesco Ltd. | 0.68% | 24.41M | $687.24M |
| 6 | JPMORGAN CHASE & CO | 0.64% | 22.99M | $647.16M |
| 7 | Robeco Institutional Asset Management B.V. | 0.59% | 21.15M | $595.35M |
| 8 | Schroder Investment Management Group | 0.44% | 15.76M | $443.60M |
| 9 | FIL LTD | 0.38% | 13.68M | $385.03M |
| 10 | Dimensional Fund Advisors LP | 0.29% | 10.38M | $292.09M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for IBN
RBI opens door for LIC in ICICI Bank (NYSE: IBN) — but how big a stake? - Stock Titan
<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxOLUI5dUFxMlZsRFZ2eXdHNWUxT2lQMnBCV0RmYlcyZ3U0cmd1Uko3eHJRMjI4NHFjNXpUcVpUQ0FSNmdXSjZyTGtSb0l2LXZGQ21rdjZ3Y29WYzYyeElmUHlKb3hGV2phR3JmYWRVal95aGFpUWdTVDdKelU0OXBUVG1QX3FYS29xbmR3Sn…
Is ICICI Bank Limited (IBN) The Best Deep Value Stock to Invest in? - finance.yahoo.com
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxNVW1Ud3NTWGQwX2hCUXhkaWx1MjA5dzBva2VydS1VYUdPNTVnTGFlcXJ1N1A2OWVtZWFFdGlEaEZwWEkxZW1HZUdUY3dYV3YzNTc3UVFpaUhWX1pWOTBBTkpFQ2JwaDFscHVkYk02eUJSNkR3aG1OT0loRVlmOTZpZXItZjJEbWI0QTlzNm…
ICICI Bank Raises Stake in ICICI Prudential Life Insurance to 52.8% - The Globe and Mail
<a href="https://news.google.com/rss/articles/CBMi5wFBVV95cUxOczZVUmZfb3NlVGt4ano2ajRGeFlxVDhDeHhtSHpyZnlpTFZXb2szSUd1NHJIR25nV0JqRzl0Yk1FbXBLeURraFVHN0Z6UW5JTHY0N0w2WUY1WTh3WTY5QjA1QkRXbmRWZDZEZHpPMndFLXBKTE1UNlhPY2FOUk5oU1lvckxwdjI4V3Y2bV…
ICICI Bank (NYSE:IBN) Stock Rating Upgraded by Wall Street Zen - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxQVnF6R1ZONVdtNUhuUkU3ZmRoME1uc3ZKRV9IajE1Zlc5N18welZDZFU2TG5MX0pNZ0NUeWdnbXd1Rl9LR1lUczNTMVBlNjRpLWgzQzVDYUdHUGVXQkY0YTV1dXo1c2ZTN0FhQU5iZGxQSU5nNkdEc01WOElqMWR0YmdsbGEzRXVydkpxU2…
IBN - ICICI Bank Ltd ADR Stock Price and Quote - Finviz
<a href="https://news.google.com/rss/articles/CBMiREFVX3lxTE9aVnJVaVVYLWR5aHI0Tmt0WnRPa2FabWl2ZURJTzYtczRPT1VXcVBKZ215ZWJpWFZXLU8xdHM5Z1BiVVl1?oc=5" target="_blank">IBN - ICICI Bank Ltd ADR Stock Price and Quote</a> <font color="…
Understanding the Setup: (IBN) and Scalable Risk - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxOcThEM3RHQks4alFqMkktOHZwVEZDUndISjRXN1A5cko2dEtwZFdZM0ZqN2dyTVlWdXg1RW9DNmpfMXJlb19zOTFlVFh3dnQ0MHQ5UTNyS2ZsREJNUHVHWV94dTUyYi00RmpBdG1yMmkzVUp4UHlkNDY4VEJUbUhfbm03YmNFMUVCZEszYm…
IBN — Frequently Asked Questions
What is the current share price of ICICI Bank Limited (IBN)?
As of 2026-09-19 21:16 PDT, ICICI Bank Limited (IBN) trades at $29.53 on NYSE. Its 52-week range is $24.99 to $33.05.
What is the market capitalisation of IBN?
ICICI Bank Limited (IBN) has a market capitalisation of $105.98B on NYSE.
What is the P/E ratio of IBN?
IBN trades at a trailing price-to-earnings (P/E) ratio of 18.34. The industry average P/E is 12.89. Its price-to-book (P/B) ratio is 2.55.
Does IBN pay a dividend?
ICICI Bank Limited (IBN) currently offers a dividend yield of 0.89%.
What is the return on equity (ROE) of IBN?
IBN has a return on equity (ROE) of 16.07%.
Is IBN a good stock to buy?
This page provides a data-driven analysis of ICICI Bank Limited (IBN), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.